Shop now

Clinically proven to treat bladder weakness

A 26-week pilot study of women with stress urinary incontinence who followed the INNOVO treatment regimen for 12 weeks found significant improvement in their symptoms:

  • An improvement in the amount of involuntary urine leaked over 1 hour in 93% of INNOVO users after 4 weeks of treatment, where 60% were defined as dry1 

1h stress test

  • An average 74% reduction in involuntary urine loss over 24 hours after 12 weeks of treatment, where 86% of INNOVO users were defined as dry or almost dry2 

24h stress test

  • An improvement in the Modified Oxford Score (standing position) after treatment with INNOVO, where 79% of patients had good or moderate pelvic floor muscle contractions at 12 weeks, compared with 6% at baseline1 

Improvement in contractility

 Patients’ pelvic floor muscle contractility improved over 12 weeks of  INNOVO treatment


Innovo is a clinical proven device
INNOVO is a clinically proven device

Download our Clinician Brochure

Learn more about the clinical study proving INNOVO's effectiveness.

Related articles

1) 1) Soeder S, Tunn R. Neuromuscular electrical stimulation (NMES) of the pelvic floor muscles using a non-invasive surface device in the treatment of stress urinary incontinence (SUI); a pilot study. IUGA Poster Presentation Conference, 2013; Dublin, Ireland.

Ask us a question